Thyroid Function Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033

Thyroid Function Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative and qualitative market trends within In Vitro Diagnostics therapeutic area.

Thyroid disease tends to be caused by structural or functional anomalies in the thyroid gland, which often result from living in iodine-deficient or iodine-excess areas and/or from autoimmune diseases such as Grave's disease and Hashimoto's disease. Additionally, other causes of thyroid disease include hypothalamus or pituitary disorders, struma ovarii, drug-induced responses, and thyroid cancer.

Thyroid Function Tests (TFTs) are performed to evaluate the function of the thyroid gland, principally in the investigation of hypothyroidism and hyperthyroidism. TFTs are generally prescribed when a patient is suspected of abnormal level of thyroid hormones. Abnormal levels of thyroid hormones in the body can cause either hyperthyroidism (high level of thyroid hormones) or hypothyroidism (low level of thyroid hormones). Evaluation of thyroid function can be done by determining the concentration of thyroid and thyroid-related hormones which are thyroxine (T), triiodothyronine (T), and thyroid stimulating hormone (TSH). TSH test, Free Thyroxine (FT4) Tests, Total Thyroxine (TT4) Tests, Free Triiodothyronine (FT3) Tests, Total Triiodothyronine (TT3) Tests, and Other Thyroid Function tests are majorly prescribed quantitative tests for accessing thyroid function. TFTs are prescribed for both the diagnosis and monitoring of hyperthyroidism and hypothyroidism.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Thyroid Function Tests and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Thyroid Function Tests market revenue by segment and market outlooks from 2015-2033.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights:

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Thyroid Function Tests market.
• Competitive dynamics insights and trends provided for Thyroid Function Tests market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Beckman Coulter Inc, Roche Diagnostics International Ltd, Siemens Healthineers AG, Abbott Laboratories, Ortho-Clinical Diagnostics Holdings Plc, Inova Diagnostics Inc and others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Thyroid function tests marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Thyroid function tests market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Thyroid function tests market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Thyroid function tests market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.